Company: BACC
Filing Date: 2025-05-14
Form Type: S-1
Source: 0001185185-25-000465
Chunk: 241

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-05-14
Form: S-1
Chunk 241
---
 shares as of the date of this prospectus, and as adjusted to reflect the sale of our Class A ordinary shares included in the units offered by this prospectus, and assuming no purchase of units in this offering, by:

| ● | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding 
 ordinary shares;                                                                                 |

| ● | each of our officers, directors and director nominees; and |

| ● | all our officers and directors as a group. |

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all of our ordinary shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the private placement rights as these rights are not convertible within 60 days of the date of this prospectus.

On February 10, 2022, Blue Holdings Sponsor LLC, our sponsor paid $25,000, or approximately $0.004 per share, to cover certain of our offering costs in exchange for 6,059,925 founder shares.

Prior to the initial investment in the company of
$25,000 by the sponsor, the company had no assets, tangible or intangible. The purchase price of the founder shares was determined by
dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding
was determined based on the expectation that the total size of this offering would be a maximum of 17,250,000 units if the underwriters’
over-allotment option is exercised in full, and therefore that such founder shares would represent 26% of the outstanding shares after
this offering (excluding the private placement shares). Up to 790,425 of the founder shares will be surrendered for no consideration depending
on the extent to which the underwriters’ over-allotment is exercised. The non-managing sponsor investors have expressed to us an
interest in purchasing up to an aggregate of approximately $[*] million of the public units, or approximately [*]%, of the public units
in this offering at the offering price (assuming the exercise in full of the underwriters’ over-allotment option). The post-offering
numbers and percentages presented in the following table assume that the underwriters do not exercise their over-allotment option, that
790,425 founder shares have been surrendered to us for no consideration and that there are 20,909,500 ordinary shares issued and outstanding
after this offering.